Debate around health systems often focuses on lives saved by new or improved medicines and fails to consider the long-term development of scientific research capacity in low and middle income countries, and how this affects the health of a country’s population and its economic growth. A recognition that health, education and industrial policy are interlinked is at the core of Innogen’s approach.